Quantcast

Latest Corticosteroid Stories

2008-12-11 18:53:00

LONDON, Dec. 11 /PRNewswire-FirstCall/ -- On December 11, 2008, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Drug Safety & Risk Management Advisory Committee, the Pediatric Advisory Committee, and the Pulmonary-Allergy Drugs Advisory Committee - completed a review of the benefits and risks of asthma medications containing long-acting beta-agonists (LABAs). The committees concluded that the benefits of AstraZeneca's SYMBICORT(R)...

2008-11-24 09:11:26

New research reveals an herb commonly used as a sleep aid could save your sight. The inflammatory eye disease, uveitis, causes sudden redness, pain and rapid vision deterioration accounts for an estimated 10 to 15 percent of cases of blindness in the United States. While there are no optimal treatments for uveitis, results of a new study suggest the herbal supplement, melatonin, may help treat the eye disease. Researchers found melatonin treatment reduced two proteins that contribute to...

2008-10-27 15:00:27

Results to be presented today at the 2008 American College of Rheumatology Annual Scientific Meeting in San Francisco, USA Galapagos NV (Euronext: GLPG) announces that Nanocort has demonstrated safety as well as a faster and more pronounced decrease in rheumatoid arthritis disease symptoms compared to reference medication. These results were obtained in an investigator driven double-blind, placebo controlled Phase I/II trial completed earlier this year at the Rheumatology Department of...

2008-10-06 21:00:11

Thai researchers suggest patients on allergy medicine are better served when they adjust their dose to symptoms. The researchers found the effectiveness of intranasal corticosteroids -- a drug that reduces swelling and secretions in the nose -- could be achieved with three-quarters of the usually recommended daily dosage when patients were instructed how to vary the daily dosage in response to severity of symptoms. This new approach to dosing could help prevent the problem of increased...

2008-10-02 15:01:05

OPKO Health, Inc. (AMEX:OPK) today announced that it has acquired exclusive worldwide rights from Teva Pharmaceuticals Industries Ltd. (TEVA) to Teva's proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye. Teva's proprietary budesonide product is currently marketed in Italy under the tradename XAVIN for the treatment of asthma. Budesonide is a corticosteroid which has been used for more than 20 years for the treatment of...

2008-09-11 15:00:09

German scientists say they have determined what conditions cause the body to deposit fat in the liver, possible leading to a fatty liver condition. Scientists have known the body's own glucocorticoid hormones, such as cortisol, promote the development of fatty liver. Long-term cortisone therapies such as those used for asthma and other chronic inflammatory diseases also cause the triglyceride level in the liver to rise to dangerous levels. Now Assistant Professor Stephan Herzig at the...

2008-07-09 09:00:12

SOUTH SAN FRANCISCO, July 9 /PRNewswire/ -- Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of noninfectious uveitis, a chronic and potentially sight-threatening inflammation of the eye. The randomized, double-masked, placebo-controlled study will evaluate the safety and efficacy of Simulect as maintenance therapy in 56 patients. During the study, patients will undergo tapering of concomitant...

2008-07-05 00:00:06

A small protein may have a big role in helping a person make more bone and less fat, researchers at the Medical College of Georgia said. Dr. Xingming Shi of the Medical College of Georgia Institute of Molecular Medicine and Genetics found the short-acting protein GILZ that appears to make this desirable shift, and wants to understand better how it does it -- with the long-term goal of targeted therapies for osteoporosis and obesity. The pathways are parallel, and the idea is if you can...

2008-06-10 09:01:15

Perrigo Company has filed an abbreviated new drug application for Fluocinonide cream 0.1%, a generic version of Vanos cream 0.1%. The company believes that it is the first to file an abbreviated new drug application (ANDA) with a Paragraph IV certification against Vanos. Perrigo filed its ANDA for Fluocinonide cream, 0.1% containing a Paragraph IV Certification with the FDA and notified Medicis Pharmaceutical, the listed patent holder of its filing. Vanos (fluocinonide) cream 0.1% is a...

2007-09-27 12:00:11

The 340B Prime Vendor Program (PVP), managed by Apexus Inc., announced today that SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available to PVP participants for the long-term maintenance treatment of asthma in patients 12 years of age and older. Effective Aug. 1, 2007, AstraZeneca is providing SYMBICORT to 340B Prime Vendor Program participants through the PVP, which provides low-cost drugs to clinics, hospitals and programs for...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related